Section of Congenital and Pediatric Cardiac Surgery, Division of Cardiac, Thoracic and Vascular Surgery, Children's Hospital of NewYork-Presbyterian/Columbia University Medical Center, 10032 New York, NY, United States.
Pediatric Cardiology Department, Children's Hospital of New York-Presbyterian/Columbia University Medical Center, 3959, Broadway BH2N, 10032 New York, NY, United States.
Arch Cardiovasc Dis. 2020 Feb;113(2):96-103. doi: 10.1016/j.acvd.2019.06.006. Epub 2019 Sep 3.
A hybrid therapy or procedure is a new treatment modality that develops by combining therapies from different subspecialties. In congenital heart disease, a growing number of such procedures have been described in recent decades, as a result of increasing collaboration between surgeons and interventionalists. The ideas behind these therapies include enabling the performance of procedures of different complexity in a less invasive manner, shortening procedural times, avoiding cardiopulmonary bypass, facilitating vascular access and decreasing the number of complications associated with more invasive approaches. Over the years, hybrid therapy has gained a place as a widely accepted therapeutic option for the management of several conditions in high-risk patients with congenital heart disease.
杂交治疗或手术是一种新的治疗模式,通过结合来自不同亚专业的治疗方法而发展起来的。在先天性心脏病中,近几十年来,随着外科医生和介入医生之间合作的增加,越来越多的此类手术得到了描述。这些治疗方法的理念包括以微创的方式进行不同复杂程度的手术,缩短手术时间,避免体外循环,便于血管通路,并减少与更具侵袭性方法相关的并发症数量。多年来,杂交治疗已经成为一种广泛接受的治疗选择,用于管理先天性心脏病高危患者的多种疾病。